Document is current
Any future updates will be listed below
-
Authors
Kunes, Russell Z.
Walle, Thomas https://orcid.org/0000-0003-4835-955X
Land, Max https://orcid.org/0009-0004-4423-9950
Nawy, Tal https://orcid.org/0000-0003-3720-3699
Pe’er, Dana https://orcid.org/0000-0002-9259-8817
- License Information
-
More Information
Article History
Received: 21 December 2022
Accepted: 9 August 2023
First Online: 21 September 2023
Competing interests
: D.P. reports equity interests and provision of services for Insitro, Inc. T.W. reports stock ownership for Roche, Astra Zeneca, Bayer, Innate Pharma, Fibrogen, Illumina and 10x Genomics as well as research funding (not related to this study) from CanVirex AG, Basel Switzerland and Institut für Klinische Krebsforschung GmbH, Frankfurt, Germany. R.Z.K., M.L. and T.N. have no competing interests.
